[artículo] 
inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.2 (Febrero) . - pp. 193-202

Título :	A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder
Tipo de documento:	texto impreso
Autores:	Adriana Feder, Autor ; Sara Costi, Autor ; Sarah B. Rutter, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 193-202
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastorno de estrés postraumático, Ketamina, Midazolam, Trauma
Resumen:	Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors’ previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion.
Link:	./index.php?lvl=notice_display&id=26873

[artículo] A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder [texto impreso] / Adriana Feder, Autor ; Sara Costi, Autor ; Sarah B. Rutter, Autor . - 2021 . - pp. 193-202.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.2 (Febrero) . - pp. 193-202

Palabras clave:	Trastorno de estrés postraumático, Ketamina, Midazolam, Trauma
Resumen:	Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors’ previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion.
Link:	./index.php?lvl=notice_display&id=26873